BCV News Alert Bancroft Convertible Fund (BCV) 20.45 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bancroft Convertible Fund (BCV) 20.45 $BCV

Bancroft Fund Ltd. Announces Earnings and Financial Update
Marketwired - Fri Feb 13, 4:00PM CST
Bancroft Fund Ltd. (NYSE MKT: BCV) today reported earnings, financial highlights and certain portfolio information for the three months ended January 31, 2015:
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Releases Monthly Portfolio Data
Marketwired - Fri Feb 13, 8:51AM CST
Bancroft Fund Ltd. (NYSE MKT: BCV) has released unaudited monthly portfolio data for January 2015 including asset allocation, representative holdings and other fund characteristics.
BCV: 20.45 (+0.06)

Bancroft Fund declares $0.25 dividend
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:08PM CST

BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Declares Quarterly Dividend, Announces Results of Annual Shareholders' Meeting and Reports on Share Repurchase Program Activity
Marketwired - Mon Feb 09, 4:00PM CST
The Board of Trustees of Bancroft Fund Ltd. (NYSE MKT: BCV) announced today that it had declared a dividend of 25 cents ($0.25) per share. The dividend is payable on March 26, 2015 to shareholders of record on March 12, 2015. Based on our current estimates, the Fund anticipates that approximately $0.198 per share of the dividend will be paid from accumulated net investment income, and approximately $0.052 per share will represent a return of capital. These estimates and the sources of the Fund's dividends and distributions are determined at the time of declaration. However dividends and distributions are subject to re-characterization for tax purposes after the end of the fiscal year. A non-taxable return of capital, if any, cannot be determined until after the end of the Fund's fiscal year. Shareholders with taxable accounts will receive written notification regarding the components and tax treatment of distributions via Form 1099-DIV.
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Announces Issue Price for the 2014 Year-End Dividend Payable on December 29, 2014
Marketwired - Mon Dec 22, 8:17AM CST
Bancroft Fund Ltd. (NYSE MKT: BCV) announced today that the price at which its beneficial shares will be issued to shareholders who elected to receive additional shares in payment of the 2014 year-end dividend will be $20.14 per share. The issue price represents the closing price of the shares on the NYSE MKT Exchange on December 19, 2014, which was below the net asset value of $23.72 per share on that date. The dividend is payable on December 29, 2014.
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Announces Increase to Share Repurchase Program and Commitment to Improving the Valuation of Its Shares
Marketwired - Thu Dec 18, 3:30PM CST
Bancroft Fund Ltd. (NYSE MKT: BCV) (the "Fund" announced today that its Board of Trustees has increased the number of shares to be acquired by the Fund pursuant to the share repurchase program announced last month. Pursuant to the revised authorization, the Fund will repurchase up to 7% of the Fund's outstanding shares (up to approximately 367,000 shares). The previous authorization was for a repurchase of up to 3% of the Fund's outstanding shares.
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Begins Share Repurchase Program
Marketwired - Tue Nov 25, 3:30PM CST
Bancroft Fund Ltd. (NYSE MKT: BCV) announced today that, in accordance with the share repurchase program recently adopted by its Board of Trustees, the Fund has begun making open market purchases of its shares. These purchases have been made in accordance with the limitations of Rule 10b-18 promulgated under the Securities Exchange Act of 1934. As previously announced, the Fund recently adopted a plan to repurchase up to 3% of the Fund's outstanding shares (up to approximately 157,000 shares). The Board of Trustees authorized the program in an effort to address the undervaluation of the Fund's shares. The extent to which the Fund repurchases its shares and the timing of such repurchases will depend on market conditions and other considerations as determined by the Fund's management team, and in accordance with the limitations of Rule 10b-18. The Fund is also allowed to purchase shares in privately negotiated transactions.
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Announces 5% Distribution Policy and 3% Share Repurchase Program
Marketwired - Wed Nov 19, 4:06PM CST
Bancroft Fund Ltd. (NYSE MKT: BCV) announced today that its Board of Trustees adopted a new 5% minimum distribution policy, effective in calendar year 2015, and a second 3% share repurchase plan. Both measures are intended to improve share valuation, and are believed to be in the best interests of shareholders.
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Declares Year-End Distribution of Investment Income and Annual Meeting Date
Marketwired - Wed Nov 19, 3:07PM CST
The Board of Trustees of Bancroft Fund Ltd. (NYSE MKT: BCV) today declared a dividend of 14.2 cents ($0.142) per share, payable on December 29, 2014 to shareholders of record November 28, 2014. The dividend consists of net investment income.
BCV: 20.45 (+0.06)

Bancroft Fund Ltd. Declares Quarterly Dividend
Marketwire - Mon Aug 18, 1:00PM CDT
The Board of Trustees of Bancroft Fund Ltd. (NYSE MKT: BCV) today declared a dividend of 12 cents ($0.12) per share, payable on September 25, 2014 to shareholders of record September 11, 2014. The dividend consists of net investment income.
BCV: 20.45 (+0.06)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Mobix Labs Innovates AI Drone Solutions for Rail Industry Growth

Updated Category News Views 129

Mobix Labs Secures AI Drone Contract Mobix Labs, Inc. (NASDAQ: MOBX), a leading provider in advanced connectivity and sensing solutions, has embarked on an exciting journey with a new contract for its Mobix Labs Wireless division, RaGE Systems. They are set to develop cutting-edge drone-based, AI-powered inspection technology specifically for the U.S. rail industry. This...

Continue Reading
Lactiga Secures NIH Grant for Groundbreaking Antibody Development

Updated Category News Views 122

Groundbreaking NIH Grant for Lactiga's Antibody Research Lactiga US, Inc., a pioneering biotechnology firm, has secured an important award from the National Institutes of Health (NIH) to enhance the development of its first-in-class secretory IgA (sIgA) antibody targeting inflammatory bowel disease (IBD). Understanding the Power of Breastmilk-Derived Antibodies This...

Continue Reading
Transforming the Intelligent Electronic Devices Market Landscape

Updated Category News Views 231

Market Growth Overview of Intelligent Electronic Devices The Intelligent Electronic Devices (IED) market is on an impressive trajectory, expected to reach USD 33.49 Billion, increasing significantly from its valuation of USD 14.35 Billion in the near future. This growth reflects a compound annual growth rate (CAGR) of 11.18% between now and 2032. The exciting advancements...

Continue Reading
Three Undervalued Energy Stocks Poised For Recovery Ahead

Updated Category News Views 100

Exploring Undervalued Energy Stocks for Portfolio Growth As market conditions fluctuate, the energy sector presents intriguing opportunities for investors seeking to enhance their portfolios. With numerous stocks labeled as oversold, there is potential for significant gains. Seeking out undervalued stocks could be a wise strategy, especially those showing a relative...

Continue Reading
Explore the Latest Blush Shades from Pixi Beauty's Range

Updated Category News Views 173

Pixi Beauty Introduces Three New Blush Shades Pixi Beauty has recently expanded its popular On-the-Glow Blush collection by adding three exciting new shades: Mauve, Cassis, and Chantilly. These versatile colors are designed to streamline beauty routines with a multi-use balm that enhances your natural beauty effortlessly. The Shift Toward Natural Beauty As the beauty...

Continue Reading